Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) have earned a consensus recommendation of “Buy” from the six research firms that are covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued ratings on the stock in […]
By Sabela Ojea Compass Pathways said early data from its post-traumatic stress disorder phase 2 clinical trial showed the psilocybin treatment was well...
Initial safety findings at 24 hours post dosing were consistent with studies of COMP360 in other psychiatric conditionsLONDON, Dec. 19, 2023 -- Compass Pathways plc , a biotechnology company...
Deutsche Bank Aktiengesellschaft started coverage on shares of COMPASS Pathways (NASDAQ:CMPS – Free Report) in a research note published on Tuesday, Marketbeat.com reports. The brokerage issued a buy rating and a $16.00 target price on the stock. Several other brokerages also recently issued reports on CMPS. Cantor Fitzgerald reaffirmed an overweight rating and issued a […]
In this article, we will be looking at the 25 best online psychology degree programs heading into 2024.